atomoxetine hydrochloride has been researched along with Developmental Disabilities in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aman, MG; Arnold, LE; Corbett-Dick, P; Handen, B; Hollway, JA; Hyman, SL; Lecavalier, L; Levato, L; Mendoza-Burcham, M; Mruzek, DW; Pan, X; Silverman, LB; Smith, T; Tumuluru, R | 1 |
| Findling, RL; Rowles, BM | 1 |
2 review(s) available for atomoxetine hydrochloride and Developmental Disabilities
| Article | Year |
|---|---|
A review of atomoxetine effects in young people with developmental disabilities.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child Development Disorders, Pervasive; Developmental Disabilities; Humans; Propylamines | 2014 |
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Clinical Trials as Topic; Clonidine; Comorbidity; Developmental Disabilities; Drug Therapy, Combination; Female; Fetal Alcohol Spectrum Disorders; Humans; Intellectual Disability; Male; Methylphenidate; Pregnancy; Propylamines; Psychotropic Drugs | 2010 |